首页> 外国专利> Formulation covered by claims 1,2,5,6,7,8,9,11 and 13 comprising any ester and pharmaceutically acceptable salts of the individual compounds Product Name: Aerinaze (Desloratadine / Pseudoephedrine)

Formulation covered by claims 1,2,5,6,7,8,9,11 and 13 comprising any ester and pharmaceutically acceptable salts of the individual compounds Product Name: Aerinaze (Desloratadine / Pseudoephedrine)

机译:权利要求1、2、5、6、7、8、9、11和13所涵盖的制剂,其包含各个化合物的任何酯和药学上可接受的盐产品名称:Aerinaze(去氯雷他定/伪麻黄碱)

摘要

A compressed bilayer solid composition comprising (a) an immediate release first layer comprising an anti-allergic effective amount of desloratadine and at least one pharmaceutically acceptable excipient and (b) a sustained release second layer comprising an effective amount of a nasal decongestant and a pharmaceutically acceptable sustained release agent wherein the composition contains less than about 2 % of desloratadine decomposition products is disclosed.
机译:压缩的双层固体组合物,其包含(a)立即释放的第一层,其包含抗过敏有效量的去氯雷他定和至少一种药学上可接受的赋形剂;和(b)持续释放的第二层,其包含有效量的鼻充血剂和药物。公开了一种可接受的持续释放剂,其中组合物含有少于约2%的去氯雷他定分解产物。

著录项

  • 公开/公告号LU91403I2

    专利类型

  • 公开/公告日2008-02-21

    原文格式PDF

  • 申请/专利权人 SCHERING CORPORATION;

    申请/专利号LU20070091403C

  • 发明设计人

    申请日2007-12-21

  • 分类号A61K9/20;A61K9/24;A61K31/137;A61K31/445;A61K31/4545;A61K31/473;A61K45;A61K47/02;A61K47/04;A61K47/12;A61K47/18;A61K47/32;A61K47/36;A61K47/38;A61P11/02;A61P37/08;

  • 国家 LU

  • 入库时间 2022-08-21 20:07:07

相似文献

  • 专利
  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号